Rocket Lab Corporation (NASDAQ: RKLB) ended Christmas Eve trading with a familiar theme: big-picture momentum remains strong, but day-to-day price action is getting choppier as the stock consolidates near recent highs.
After-hours / late-session check: As of 8:00 p.m. ET on Dec. 24, 2025, RKLB was indicated at $77.80, up $0.62 (+0.80%) from the regular-session close of $77.18, according to Public’s after-hours quote page.
One important calendar note that changes how traders should read today’s tape: U.S. equity markets closed early at 1:00 p.m. ET for Christmas Eve, and Nasdaq’s late session also ran on an early schedule (ending at 5:00 p.m. ET).
Also crucial: there is no U.S. stock market open tomorrow (Thursday, Dec. 25, 2025) for Christmas Day. The next full trading day is Friday, Dec. 26, 2025.
RKLB’s Christmas Eve price action: wide range, flat finish
Even with the shortened session, Rocket Lab traded with meaningful intraday volatility.
- Close (Dec. 24): $77.18
- Day’s range: roughly $74.80 to $79.83
- Volume: about 16.6 million shares
That’s an intraday swing of about $5.03 (roughly 6.5% of the close), which is notable for a stock already coming off a powerful multi-day surge.
The broader market context matters here too: today’s Christmas Eve session was holiday-shortened and notably light in overall trading activity, with major indexes closing at or near record highs in thin volume.
Why that matters for RKLB: with less liquidity, price moves can look “louder” than they would on a normal full session—especially in high-beta, retail-popular names where options positioning can influence short-term flows.
The main fundamental driver remains the Space Development Agency contract
While today’s company-specific headline flow was relatively quiet (typical for Christmas Eve), the dominant catalyst still shaping RKLB sentiment is the Space Development Agency (SDA) Tracking Layer Tranche 3 award announced last week.
Rocket Lab disclosed (via an SEC-filed release) that it was awarded an $816 million prime contract to design and manufacture 18 satellites for the SDA’s Tracking Layer Tranche 3 (TRKT3) program. The company described it as its largest single contract to date, and specified the award includes an $806 million base contract plus up to $10.45 million in options.
Rocket Lab also said the satellites will include:
- its Phoenix infrared sensor payload, and
- StarLite protection sensors designed to help defend against directed-energy threats.
In the same release, Rocket Lab added a key “upside” detail investors continue to debate: beyond the $816M prime award, the company sees additional subsystem opportunities supplying other primes that could take total capture value to ~ $1 billion across payloads, solar solutions, ADCS components, software, and other systems. SEC
Reuters, covering the broader program, reported the SDA placed $3.5 billion in contracts for 72 satellites (18 each) among Rocket Lab and other major defense contractors, with deployment planned by 2029.
Bottom line: RKLB is being repriced not just as a launch provider, but increasingly as a national-security space prime and merchant supplier, which is exactly the narrative that’s been pulling in incremental analyst optimism.
Launch execution remains a core pillar of the bull case
The other “sticky” catalyst is operational credibility.
Rocket Lab completed its final mission of 2025 on Dec. 21, successfully placing the Japanese Earth-observing satellite QPS-SAR-15 into orbit on an Electron rocket. Space.com notes the mission capped Rocket Lab’s 21st launch of the year, setting a new annual record for the company.
Investopedia also pointed to the combination of the weekend launch success and the defense contract win as a key reason Rocket Lab shares surged earlier this week.
Why this still matters heading into the next session: the market is treating Rocket Lab’s cadence and reliability as proof points that can support scaling ambitions—particularly as investors look ahead to Neutron, Rocket Lab’s medium-lift rocket still in development and widely viewed as the next major valuation “unlock” if execution goes well. MarketWatch+1
Analyst forecasts: $90 becomes the headline target, but “consensus” is mixed
A major part of what traders are reacting to late this week is the wave of target hikes following the SDA award and the launch milestone.
- Needham raised its Rocket Lab price target to $90 (from $63) while maintaining a Buy rating, according to multiple market reports circulating this week.
- Barron’s and other outlets highlighted the broader trend: Rocket Lab stock’s December surge has put the company in the spotlight, with analysts framing the business as increasingly relevant to defense and space infrastructure demand.
However, here’s the nuance that matters for “what to know before the next open”:
Not all consensus aggregations are chasing the stock at these levels. For example, MarketBeat’s aggregated view shows an average 12‑month price target below the current trading range (even while listing a high target at $90).
That divergence—some analysts hiking aggressively while aggregates lag—often shows up when a stock moves fast and coverage updates don’t all arrive at once.
Today’s Rocket Lab analyses and commentary: valuation debate + options traders get active
Because you asked specifically for today’s forecasts and analysis, here are the notable pieces dated Dec. 24, 2025, and what they imply for the next session:
1) Simply Wall St: “Valuation check” highlights upside narratives—and premium multiples
A Simply Wall St piece dated Dec. 24, 2025 frames Rocket Lab as potentially still undervalued under a “fair value” narrative that lands near ~$98/share, while also flagging that the stock trades at a very elevated price-to-book multiple versus aerospace and defense peers—meaning sentiment could turn quickly if execution stumbles. Simply Wall St
What to take away into Friday: the market is starting to split into two camps:
- “This is the early innings of a defense-space prime,” vs.
- “The stock is priced for near-flawless execution.”
That tension is often where volatility comes from.
2) Barchart: bullish diagonal spread targets $85 by mid‑January (and flags overbought conditions)
A Barchart options-focused column dated Dec. 24 lays out a bullish diagonal spread example positioning for a move toward $85 by Jan. 16, while noting Rocket Lab’s technical posture and explicitly flagging RSI above 70 (overbought territory) and the possibility of a reversal if momentum breaks.
What to take away into Friday: options commentary is a signal that:
- traders still see upside scenarios,
- but are increasingly structuring defined-risk trades rather than chasing shares outright.
3) AInvest: defense-driven growth narrative (high conviction tone)
An AInvest article dated Dec. 24 leans hard into the “defense prime” storyline, tying the SDA win to backlog strength and national security demand, while citing the Needham target hike as validation. AInvest+1
What to take away into Friday: even if you discount the outlet’s tone, it’s a proxy for broader retail/internet narrative strength—useful for gauging sentiment, especially in a stock where sentiment can matter short term.
What to know before the next market open (Friday, Dec. 26, 2025)
Since Dec. 25 is a full market holiday, the actionable “tomorrow” setup is really the Friday, Dec. 26 open. NASDAQ Trader+1
Here are the most important items to have on your radar:
1) Liquidity and gap risk are elevated into the post‑holiday session
- Today was a shortened session with thin market-wide volume—a backdrop that can exaggerate moves in high-beta names.
- Nasdaq’s own holiday notice reiterates the early close dynamics and confirms normal operations resume Friday.
Practical implication for RKLB: expect wider spreads at times, more gap-prone opens, and potentially faster squeezes/dips than usual if large orders hit a thin book.
2) Watch whether RKLB reclaims (or rejects) the ~$79–$80 zone quickly
Today’s session printed a high near $79.83 and a low near $74.80, then stabilized into the close—classic consolidation behavior after a vertical run.
Why this matters: strong momentum names often tell you quickly whether they’re:
- building a base for another leg higher, or
- entering a profit-taking phase.
3) The “SDA contract trade” is still the driver—look for secondary confirmation
The contract details (value, satellites, payloads, options, and the “total capture” discussion) are now well known. SEC+1
So the next catalyst layer tends to be:
- follow-on commentary from analysts,
- additional supplier/partner mentions,
- or any program timing details that change revenue/backlog conversion assumptions.
4) Keep Neutron expectations in perspective
Media coverage this week repeatedly points to Neutron as the next major milestone investors care about—even if the nearer-term revenue narrative is increasingly about defense space systems.
Why this matters into Friday: high expectations can act like gravity. When a stock is priced for big future wins, it can rally on good news—but also drop sharply on “not-perfect” updates.
5) Earnings timing: the next major scheduled catalyst is late February
Zacks lists Rocket Lab’s next earnings as expected Feb. 26, 2026 (estimated). Zacks
Rocket Lab’s own IR site has highlighted recent operating momentum (including Q3 2025 record revenue) in prior updates, and the street will start “gaming out” Q4 and 2026 guidance well before the report. investors.rocketlabcorp.com
Why this matters now: in the absence of fresh company news during the holiday, traders often rotate attention back to:
- valuation vs. forward revenue,
- backlog conversion pace,
- and margin trajectory (especially in the Space Systems segment).
6) Macro backdrop remains supportive—but don’t overfit it
Today’s broader tape was upbeat, with U.S. stocks closing higher in the holiday-shortened session and attention turning to the seasonal “Santa rally” period. Reuters+2MarketWatch+2
RKLB has its own idiosyncratic catalysts, but high-momentum growth/space names can still be sensitive to:
- risk-on / risk-off swings,
- rate expectations,
- and post-holiday positioning.
The setup in one sentence
Rocket Lab (RKLB) ended Dec. 24 essentially flat on the day, then ticked higher in late trading—while the market continues to debate whether the SDA contract win and launch execution justify a new, higher valuation regime or whether the stock is simply priced too richly after a historic run.
This article is for informational purposes only and is not investment advice.
